WIREs Nanomedicine and Nanobiotechnology
- The first title in the innovative WIREs publication series
- An authoritative, encyclopedic resource addressing key topics from the perspectives of medicine, biology, physics, chemistry, and engineering
- High-quality content commissioned from expert contributors and peer-reviewed to a rigorous standard
- Content is fully citable, qualifying for abstracting, indexing, and ISI ranking
Latest Articles
Editorial Commentary
Opinions
Overviews
Advanced Reviews
- Near infrared imaging with nanoparticles
- New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders
Focus Articles
Featured Collection Topic Commentaries
Mapping climate change knowledge: An editorial essay
(from WIREs Climate Change)
Editorial Commentary
Mike Hulme
Why do we care about past climates? an editorial essay
(from WIREs Climate Change)
Editorial Commentary
Neville Nicholls
Climate models and modeling: an editorial essay
(from WIREs Climate Change)
Editorial Commentary
Hans von Storch
Behaviour, perceptions, and communication of climate change
(from WIREs Climate Change)
Editorial Commentary
Lorraine Whitmarsh, Irene Lorenzoni
Access to this WIREs title is free to registered institutions.
Register Your Institution Now!The latest WIREs articles in your inbox
Sign Up for Article AlertsIn the Spotlight
Scott McNeil
Dr. McNeil is the director of the Nanotechnology Characterization Laboratory for the National Cancer Institute, where he conducts preclinical characterization of nanoparticles intended for cancer therapy and diagnosis. The NCL evaluates nanomaterials using an "assay cascade," which includes physicochemical, in vitro, and in vivo characterization. In laymen's terms, they help cancer researchers get their nanotech-based particles from the lab bench into clinical trials.
